Skip to main content
IET Nanobiotechnology logoLink to IET Nanobiotechnology
. 2019 Apr 17;13(4):449–455. doi: 10.1049/iet-nbt.2018.5029

Evaluation of antibacterial property of hydroxyapatite and zirconium oxide‐modificated magnetic nanoparticles against Staphylococcus aureus and Escherichia coli

Mahboobeh Rad Goudarzi 1, Mojtaba Bagherzadeh 2,, Mohammad Fazilati 1, Fariborz Riahi 2, Hossein Salavati 3, Samaneh Shahrokh Esfahani 4
PMCID: PMC8676336  PMID: 31171751

Abstract

In the first section of this research, superparamagnetic nanoparticles (NPs) (Fe3 O4) modified with hydroxyapatite (HAP) and zirconium oxide (ZrO2) and thereby Fe3 O4 /HAP and Fe3 O4 /ZrO2 NPs were synthesised through co‐precipitation method. Then Fe3 O4 /HAP and Fe3 O4 /ZrO2 NPs characterised with various techniques such as X‐ray photoelectron spectroscopy, X‐ray diffraction, scanning electron microscopy, energy dispersive X‐ray analysis, Brunauer–Emmett–Teller, Fourier transform infrared, and vibrating sample magnetometer. Observed results confirmed the successful synthesis of desired NPs. In the second section, the antibacterial activity of synthesised magnetic NPs (MNPs) was investigated. This investigation performed with multiple microbial cultivations on the two bacteria; Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). Obtained results proved that although both MNPs have good antibacterial properties, however, Fe3 O4 /HAP NP has greater antibacterial performance than the other. Based on minimum inhibitory concentration and minimum bactericidal concentration evaluations, S. aureus bacteria are more sensitive to both NPs. These nanocomposites combine the advantages of MNP and antibacterial effects, with distinctive merits including easy preparation, high inactivation capacity, and easy isolation from sample solutions by the application of an external magnetic field.

Inspec keywords: nanocomposites, X‐ray chemical analysis, microorganisms, magnetic particles, scanning electron microscopy, precipitation (physical chemistry), nanomagnetics, X‐ray diffraction, X‐ray photoelectron spectra, nanoparticles, superparamagnetism, iron compounds, antibacterial activity, biomedical materials, nanomedicine, calcium compounds, nanofabrication, Fourier transform infrared spectra, magnetometers, zirconium compounds

Other keywords: antibacterial effects, antibacterial property, superparamagnetic nanoparticles, X‐ray photoelectron spectroscopy, X‐ray diffraction, X‐ray analysis, antibacterial activity, bactericidal concentration, S. aureus bacteria, Staphylococcus aureus, Escherichia coli, hydroxyapatite, coprecipitation method, scanning electron microscopy, energy dispersive X‐ray analysis, Brunauer‐Emmett‐Teller method, Fourier transform infrared spectroscopy, vibrating sample magnetometer, microbial cultivations, nanocomposites

1 Introduction

Nowadays, antibiotic resistance, due to human misuse and disregard, becomes a serious public health concern throughout the world [1, 2]. Between them, nanomaterials have an important role in this research area. However, for consideration of nanoparticles (NPs) in biological applications, such as antibacterial therapeutics, several key requirements have to be fulfilled. The first is to deal with the engineered NPs of biocompatibility. The second implies manipulation of the simple carriage to the desired location. Finally, the most crucial requirement is their easy separation from the biological environment. Despite the very fast expansion of the bio‐nanotechnology in recent years, there are many challenges facing these three requirements. Relevant works that aimed at correlating synthesis, stabilisation and surface modification of NPs with their biological effects and decreased toxicity have shown that there is no general role.

Application of NPs offers many advantages due to their unique size and physical properties [3]. For most types of uses, to impede biocompatible particles and their stability in the carrier liquids, complex structure type magnetic core/non‐magnetic shell is required. Magnetic NPs (MNPs) have a wide range of uses in various disciplines, such as biomedical applications catalysis, biotechnology, biomedicine, magnetic resonance imaging, and environmental remediation [4]. In this regard, using MNPs in controlling bacterial infection is carried out by many researchers [5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19]. Iron oxides are somewhat stable against oxidation and have a significant magnetisation, and also due to their lack of toxicity being preferred in various uses [11, 20, 21]. Superparamagnetic NPs have been extremely studied due to their varied applications, in both physico‐chemical and biomedical fields. Candidate MNPs for biomedical uses are mainly biocompatible Fe3 O4 NPs which can be coated with organic and inorganic agents able to ensure active biochemical agents grafting on the functionalised surface of MNPs.

The antibacterial effects of ZnO, Al2 O3, CuO, TiO2, NiO and iron oxide NPs have been previously reported [22, 23, 24, 25, 26, 27, 28, 29]. Metallic NPs, as a result of their antibacterial properties, act as an effective agent against bacterial resistance [30]. MNPs because of their special physical properties such as ease of preparing nanosize material and good magnetic effect and the possibility to attach with microbial cells, have a lot of applications in biomedicine and biologic systems. The synergistic effect of MNPs as antimicrobial agents is previously studied [5, 11]. Recently, antibacterial agent‐modificated MNPs, were used to improve their activity and easy separation of them from environment by applying an external magnetic field, such as Ag NPs [7, 9, 14, 16, 18], Au NPs [12, 31], N‐halamine [8], polyrhodanine [13], poly(vinyl pyrrolidone) [15], alumina [19], cetyltrimethylammonium bromide [32], and TiO2 [6].

Other interesting agents that have been used for antibacterial application are hydroxyapatite (HAP) [33, 34] and zirconium oxide (ZrO2) [35, 36, 37]. It seems highly promising to modification of MNPs with them and enhanced the antibacterial property and dedicate to them magnetic property to easy separation. In spite of this interesting combination, there is no report on the preparation of ZrO2 and HAP‐modified MNPs as antibacterial agents against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli).

This work aims to synthesise of Fe3 O4 MNPs by chemical co‐precipitation method and to modify its surface with ZrO2 and HAP, i.e. Fe3 O4 /ZrO2 and Fe3 O4 /HAP nanocomposites. After that, characterisation of nanocomposites by X‐ray diffraction (XRD), Fourier transform infrared (FTIR), scanning electron microscopy (SEM), transmission electron microscopy (TEM), vibrating sample magnetometer (VSM) techniques and subsequently, evaluation of their antibacterial activity by treating with S. aureus and E. coli. To the best of our knowledge, the synergistic influence of modified MNPs (Fe3 O4 /ZrO2 and Fe3 O4 /HAP) as an antibacterial agent is not yet reported in the literature.

2 Experimental

2.1 Chemicals and materials

All reagents were of analytical reagent‐grade and used as supplied. Ferric chloride (FeCl3 ·6H2 O), ferrous chloride (FeCl2 ·4H2 O), calcium nitrate (Ca(NO3)2 ·4H2 O), potassium di‐hydrogen phosphate (KH2 PO4), zirconium chloride (ZrCl4), barium chloride (BaCl2), sulphuric acid (H2 SO4), hydrochloric acid (HCl), perchloric acid (HClO4), acetic acid (CH3 COOH), sodium hydroxide (NaOH), Nutrient broth and nutrient agar were purchased from Merck®. All solutions were prepared with purified water (18 MΩ cm, Millipore‐MilliQ, Millipore Inc.).

Two bacteria chosen for investigations of the antibacterial assay were one Gram‐positive bacteria such as S. aureus ATCC 25923 and one Gram‐negative bacteria E. coli ATCC 25922 supplied from microbiology department, Esfahan University, Esfahan, Iran. Bacterial cultures were prepared in Nutrient Broth and maintained for 24 h at 37°C. The cell suspensions were diluted with sterile nutrient broth to provide an initial cell count of about 106 CFU/ml.

2.2 Preparation of Fe3 O4 MNPs

The Fe3 O4 NPs were prepared by chemical coprecipitation methods [38, 39]. Briefly, 5.2 g of FeCl3 ·6H2 O, 2.0 g of FeCl2 ·4H2 O were dissolved in 25 ml 1 M of HCl (degassed with nitrogen gas before use for 20 min). Then, the solution was added dropwise to 250 ml of 1.5 M NaOH solution under vigorous stirring using a magnetic stirrer at 80°C. The obtained Fe3 O4 NPs were separated from the reaction medium by magnetic field, and washed with 200 ml deionised water four times, then resuspended in 100 ml deionised water and used for the next section.

2.3 Preparation of Fe3 O4 /ZrO2 NPs

The Fe3 O4 /ZrO2 NPs were synthesised based on our previous reported work [40]. Briefly, fresh solution of Zr(IV), prepared from zirconium tetrachloride in 0.23 M in HClO4 solution, was added dropwise to the Fe3 O4 suspension and the pH value was adjusted to 8.0 by the addition of 2 M NaOH solution within 1 h. Stirring of the mixture carried on for 2 h after the addition. In the whole of process, temperature maintained at 80°C and for removal of oxygen, nitrogen gas bubbled in the suspension. The mass ratio of Fe3 O4 to ZrO2 prepared in this work was 2:5. Finally, the formed NPs thoroughly washed and resuspended in deionised water.

2.4 Preparation of Fe3 O4 /HAP MNPs

For preparation of the Fe3 O4 /HAP, firstly 16.530 gr Ca(NO3)2. 4H2 O and 5.715 gr KH2 PO4 were weighed and dissolved in a 100 ml volumetric flask. Then, 2.1 ml glacial acetic acid added to this solution and after that, diluted carefully to 100 ml with deionised water. 1 gr Fe3 O4 NPs prepared in the previous section, added to this freshly prepared solution and the resulted suspension mixed thoroughly for 30 min. Thereafter, NaOH 2 M solution dropwise added to the suspension and the pH value of the mixture was adjusted to 13. Suspension preserved 6 h in 37°C. Finally, the formed Fe3 O4 /HAP NPs thoroughly washed with deionised water and resuspended in deionised water and then separated by a permanent magnet. The mass ratio of Fe3 O4 to HAP prepared in this work was 1:5.

2.5 Apparatuses and methods

The XRD patterns and the crystal structure of prepared NPs were analysed by X‐ray diffractometer (XRD, Bruker Advanced D8 model), using CuKα radiation (λ  = 1.5406 Å). Morphology and elemental analysis of the samples determined by scanning electron microscope (SEM) equipped with EDXA (Philips XL‐30). The size of the as‐prepared particles was characterised using transmission electron microscope, TEM, (Philips‐EM‐208S). Magnetic properties were analysed using a vibrating sample magnetometer (VSM, Daghigh Meghnatis Kashan Co., Kashan, Iran). FTIR spectroscopy analysis was performed with a Nicolet Impact 400D Model spectrophotometer (Nicolet Impact, Madison, USA). pH meter (EDT Instrument, England), incubator (Heraeus, Germany), Oven (Memert, Germany), Autoclave (model A‐1000, Abzar teb, Iran) were also used in antibacterial experiments. Optical density (OD) of the samples was determined by UV–vis Cintra Model 404.

Standard of 0.5 McFarland barium sulphate prepared by adding 0.5 ml 0.048 M of BaCl2 solution to the 99.5 ml 0.18 M of sulphuric acid solution and after that by consecutive mixing, a suspension prepared. Exact density of standard turbidity determined using a spectrophotometer and recording absorption value in 625 nm, which (must be in the range of 0.08–0.13). 5 ml of BaCl2 suspension transferred to the tubes with equal size and maintained in the dark and room temperature.

2.6 Preparation of culture medium

According to the procedure of supplier, 8 g of nutrient broth powder and 30 g of nutrient agar weighed and separately dissolved in 1 l deionised water and then transferred to the tubes and subsequently by closing tubes inlet by cotton, sterilised during 15 min by an autoclave in 121°C and 15 Pa. For investigation of bactericidal effects of nanomaterials, from each of two bacteria and after night cultivation, a turbidity equal to 0.5 McFarland (OD600  = 0.132) prepared. Then from each one up to 10% Vol secondary culture media impregnated to the tubes contain nutrient broth in three groups. Distribution of NPs in three groups of tubes were, 0.075, 0.15, 0.3, 0.6 and 0.9% of Fe3 O4, 0.075, 0.15, 0.3, 0.6 and 0.9% of Fe3 O4 /HAP and 0.075, 0.15, 0.3, 0.6 and 0.9% of Fe3 O4 /ZrO2 NP. For blank sample also this proportion of bacteria added to the tubes contain culture media without NPs. If NPs create turbidity in the suspension, to compensate it one group consider as a negative control. An inlet of tubes closed with cotton and after shaking placed in the incubator for night culture at 37°C. A mentioned examination carried out in three series. Samples also examined for minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) tests. Statistical evaluations were performed by using Minitab 16 software and balanced ANOVA method.

2.7 Antibacterial assay of NPs

The bactericidal efficacy was assayed by measuring OD of incubated samples with a UV–vis spectrophotometer [41].

After 24 h incubation, firstly MIC of samples evaluated and after that for determining MBC, all tubes without turbidity separately cultured on the nutrient agar plate and subsequently incubated 24 h in 37°C. In the next step, the OD value of samples undergoes first incubation determined. For this reason, firstly NP separated by a permanent magnet and then OD at 600 nm in comparison with blank and control samples determined. This test performed on the three series of samples and the average value of each sample was determined. After 24 h incubation at 37°C, to determining MBC value, plates were inspected and minimal concentration which growing of bacteria not occurred reported as MBC value in the presence and absence of Fe3 O4 /HAP and Fe3 O4 /ZrO2 NPs.

3 Results and discussion

3.1 Characterisation of prepared NPs

XRD : The XRD patterns of the as‐prepared Fe3 O4 /HAP (b) and Fe3 O4 /ZrO2 (b) NPs in comparison to pure Fe3 O4 (a) are shown in Fig. 1. Comparison of the XRD patterns of the pure sample Fe3 O4 and modified Fe3 O4 with HAP and ZrO2 MNPs revealed the existence of HAP and ZrO2 in addition to Fe3 O4 structure in the resulting particles. As shown in the pattern (b) the diffraction peaks at d ‐values of 2θ  = 22°, 25.8°, 28.6°, 32.7°, 34° and 50° were indexed to (100), (200), (210), (300), (202) and (310) planes of HAP, respectively. It is also, the diffraction peaks at d ‐values of 2θ  = 30.4°, 35.2°, 50.6° and 60.3° were indexed to (111), (200), (220), and (311) planes of zirconium oxide, respectively [40]. The diffraction peaks observed at d ‐values of 2θ  = 30.0°, 35.5°, 57.2°, 62.7° and 89.9° were indexed to (220), (311), (511), (440), and (731) planes of magnetite, in which demonstrated no impurity peaks are detected and the high purity Fe3 O4 spinel structure is synthesised (pattern (a)). From the XRD patterns, the average size of dispersed Fe3 O4 /HAP and Fe3 O4 /ZrO2 NPs were calculated using Scherer equation as 27 ± 1 and 10 ± 2 nm, respectively.

Fig. 1.

Fig. 1

XRD patterns of the as prepared Fe3 O4 (a), Fe3 O4 /ZrO2 (b) and Fe3 O4 /HAP(c)

FTIR: To further prove successful preparation of nanomaterials, the FTIR spectroscopy was employed to examine the surfaces of the as‐made Fe3 O4, Fe3 O4 /HAP and Fe3 O4 /ZrO2 NPs. The characteristic band of Fe3 O4 appears at ~576 cm−1 (Fig. 2 spectra a) [42]. The FTIR spectrum of the Fe3 O4 /HAP NPs (Fig. 2 spectra b) shows characteristic bands at 603, 566, 1035 and 1420–1576 cm−1, which is due to the stretching and bending modes of PO4 3– the bond of HAP [43]. Furthermore, observed peak around 872 cm−1 is related to P–O band. The FTIR spectrum of the Fe3 O4 /ZrO2 NPs (Fig. 2 spectrum c) shows bands at 500–850 cm−1, which is the characteristic bond of Zr–O [37].

Fig. 2.

Fig. 2

FTIR spectrums of the as prepared Fe3 O4 (a), Fe3 O4 /ZrO2 (b) and Fe3 O4 /HAP(c)

Hence, these FTIR spectroscopy results provide additional evidence for the successful synthesis of NPs. The results support the presence of HAP and ZrO2 on the surface of MNPs, and thus, modifications took place on the Fe3 O4 NPs, i.e. the resulted Fe3 O4 /HAP and Fe3 O4 /ZrO2 MNPs have unique behaviours of HAP and ZrO2 in addition to magnetic property, respectively.

SEM and EDXA : The morphology and elemental structure of as‐prepared Fe3 O4 /HAP and Fe3 O4 /ZrO2 particles were further examined by SEM (Fig. 3) and EDXA (Fig. 4). As displayed in Fig. 3 A, the morphology of bulk Fe3 O4 particles is irregular and predicted agglomeration take place between them. Observed SEM images for bulk Fe3 O4 /HAP and Fe3 O4 /ZrO2 particles in Figs. 3 B and C, respectively, showed condensed irregular particles. Chemical analysis using EDXA shows the presence of Zr atom in the Fe3 O4 /ZrO2, as shown in Fig. 4 A, and Ca, O and P elements in the Fe3 O4 /HAP particles, as shown in Fig. 4 B. Obtained evidence from EDXA along with XRD and FTIR results confirmed successful preparation of Fe3 O4 /HAP and Fe3 O4 /ZrO2 particles.

Fig. 3.

Fig. 3

SEM images of

(A) As‐prepared Fe3 O4, (B) Fe3 O4 /ZrO2 and (C) Fe3 O4 /HAP. The scale bars are 3, 3 and 10 µm in SEM images (A), (B) and (C), respectively

Fig. 4.

Fig. 4

EDXA of

(A) As‐prepared Fe3 O4 /HAP, and (B) Fe3 O4 /ZrO2

TEM : Figs. 5 A and B show the typical TEM images of the as‐prepared Fe3 O4 /HAP and Fe3 O4 /ZrO2 NPs, respectively. As displayed, the particles exhibited spherical morphology but with a small tendency to agglomeration and also the as‐prepared particles still in nanometre size during the preparation process. From TEM images, the average size of dispersed Fe3 O4 /HAP and Fe3 O4 /ZrO2 NPs was estimated as 35 ± 5 and 12 ± 4 nm, respectively. The TEM images and corresponding XRD patterns and EDXA, strongly suggested that the spherical, HAP and ZrO2 particles are made up of a large number of small‐sized tetragonal Fe3 O4 nanocrystallites.

Fig. 5.

Fig. 5

TEM images of

(A) As‐prepared Fe3 O4 /HAP, and (B) Fe3 O4 /ZrO2. The scale bars are 200 and 100 nm in TEM images (A) and (B), respectively

VSM : MNPs synthesised here possess superparamagnetic behaviour with strong magnetic power. Figs. 6 A and B show the VSM magnetisation curves of Fe3 O4 /HAP and Fe3 O4 /ZrO2 MNPs. The saturation magnetisation curves as 5.1 and 10.04 emu g−1 were observed for Fe3 O4 /HAP and Fe3 O4 /ZrO2 MNPs, respectively. Those saturation magnetisation curves were high enough for magnetic separation. The results proved the MNPs exhibited typical superparamagnetic behaviour, characterised with strong magnetic susceptibility and no hysteresis, remanence and coercivity (Table 1). The reaction of prepared MNPs in a magnetic field by applied a permanent magnet also presented in Fig. 6 B. These results verified the successful synthesis of Fe3 O4 /HAP and Fe3 O4 /ZrO2 MNPs and superparamagnetic behaviour of them.

Fig. 6.

Fig. 6

The magnetic responses

(A) Magnetic hysteresis loops of the as prepared Fe3 O4 /ZrO2 (a), and Fe3 O4 /HAP (b), (B) Reaction of prepared MNPs in a magnetic field by applied a permanent magnet. The suspension of nanomaterials transparent after 10 min (left picture)

Table 1.

MIC and MBC results for each NP and bacteria

Sample Microorganism MIC, % MBC, %
Fe3 O4 S. aureus 0.9 1.2
E. coli 0.9 1.5
Fe3 O4 /HAP S. aureus 0.15 0.3
E. coli 0.15 0.6
Fe3 O4 /ZrO2 S. aureus 0.3 0.6
E. coli 0.3 0.9

3.2 Antibacterial studies

Prepared MNPs, Fe3 O4 /HAP and Fe3 O4 /ZrO2, were tested as antibacterial agents. For this purpose, Fe3 O4 /HAP and Fe3 O4 /ZrO2 MNPs were added to the S. aureus and E. coli bacteria culture medium in different concentration. Figs. 7, 8, 9 show the growth rate of S. aureus and E. coli bacteria in nutrient broth medium in different percentage of Fe3 O4, Fe3 O4 /HAP and Fe3 O4 /ZrO2, respectively. The balanced ANOVA by using Minitab 16 software was used to compare the observed results in Figs. 7, 8, 9. P value ≤0.05 was considered as a signifier.

Fig. 7.

Fig. 7

Effect of different concentration of Fe3 O4 on S. aureus and E. coli activity

Fig. 8.

Fig. 8

Effect of different concentration of Fe3 O4 /HAP on S. aureus and E. coli activity

Fig. 9.

Fig. 9

Effect of different concentration of Fe3 O4 /ZrO2 on S. aureus and E. coli activity

Statistically, there was no significant difference between the type of bacteria, S. aureus and E. coli, (P >0.05), indicating that prepared nanomaterials have the same effect on the S. aureus and E. coli. However, there was a significant difference between the types of used nanomaterials. Based on the P value, Fe3 O4 /HAP NP has greater antibacterial performance than Fe3 O4 (P  = 0.05) and there was no significant difference between Fe3 O4 /HAP and Fe3 O4 /ZrO2 (P  = 0.18), and Fe3 O4 and Fe3 O4 /ZrO2 (P  = 0.57). Furthermore, the MBC/MIC test was performed for approval that Fe3 O4 /HAP has more strength bactericidal property than Fe3 O4 /ZrO2 and Fe3 O4. After 24 h incubation of plates in 37°C, MIC and MBC of Fe3 O4 /HAP and Fe3 O4 /ZrO2 NPs were investigated and thereby lowest concentration in which bacterial growth not occurred reported as MBC value (Table 1). According to the obtained results and refer to Figs. 7, 8, 9, it is obvious that bactericidal effects of Fe3 O4 were weaker but when its surface modified with HAP and ZrO2, this effect significantly increased and the threshold limit of concentration was lower than Fe3 O4 NPs. Also, it's obvious that the bactericidal effect of Fe3 O4 /HAP is better than Fe3 O4 /ZrO2 and this effect against S. aureus is greater than E. coli.

3.3 Antibacterial mechanism of Fe3 O4 /HAP and Fe3 O4 /ZrO2 NPs

Various investigations showed that the cell wall of bacteria has a great role against NPs. Generally, in gram (+) and (−) bacteria its behaviour is different. NPs via the assistance of electrostatic interaction, can connect to the outer membrane of bacteria and cause to disturbing the membrane, suppressing of preplasmic enzymes, rupture of bacteria cell in the culture media, and ultimately restraining of DNA and RNA and protein synthesis. When NPs enter the bacterial cell, it forms a low‐molecular‐weight region in the centre of the bacteria to which the bacteria conglomerates, thus, protecting the DNA from the metal. The NPs preferably attack the respiratory chain, the cell division finally leading to cell death [44, 45, 46]. Furthermore, functionalised NPs release their metallic ions in the vicinity of cell wall which would cause diffuse into the cell and then based upon toxicity mechanism cause injury of bacteria [47, 48].

Because of their complex cell wall structure, gram (−) bacteria are more resistant against NPs and in this regard may be more amount of NPs and more retention time needed for better bactericidal effect. Also, some gram (+) bacteria, such as S. aureus with the formation of biofilm creates more resistance against NPs. It is possible that released ions from nanomaterials react with thiol groups (−SH) of bacteria cells surface proteins. The function of some of these cell membrane proteins is minerals transferring from the cell membrane. The NPs effect on this protein caused inactivation and impenetrable of the cell wall [49]. Inactivation of membrane permeability caused the death of the cell. Metal oxide NPs, based on their surface‐to‐volume ratio showed different bactericidal properties. Attachment of some metallic ions to DNA of bacteria would prevent certain important transferring processes such as carrying of phosphate and succinate agents and can interact with cell oxidation processes and breathing chains [50, 51, 52].

Recent studies on Fe3 O4 NPs shows that they can cause to leakage of lactate dehydrogenase from the cell membrane, a disorder in mitochondria function (or operation), the aggregate of chromosomes and creation of oxygen free radicals.

Formation of the oxygen free radicals, cause to disorder in oxidative pressure, cell antioxidant system and also peroxidation of membrane lipids, oxidation of enzymes and structural proteins, breaking of the DNA molecule and finally death of cells [53, 54, 55]. These particles caused erosion of plasmatic membrane, the creation of bubbles towards out of cell and disorder in permeability of plasmatic membrane [56, 57, 58] – microorganisms attachment to the host cells and tissues used by the surface adhesion factors. Attachment of Fe3 O4 NPs to the cell wall and surface factors of microorganisms leading to the occupation and inactivation of adhesion factors and as a result prevent its connection to the host cell substrate. This effect proved in S. aureus cells [59].

The existence of magnetic fields in iron oxide NPs helps it to penetrate the biofilm of bacteria. However, Fe3 O4 NPs are physicochemically unstable. These substances in the presence of oxygen quickly oxidised and converted to Fe2 O3 and because of their magnetic and hydrophobic properties are very unstable in aqueous and biological media. So its surface for better use needed to be coated [60, 61].

Herein, Fe3 O4 NPs modified with HAP and ZrO2. Antimicrobial activity of HAP is related to the release of OH ions in an aqueous environment. Hydroxyl ions are highly oxidant free radicals that show extreme reactivity, reacting with several biomolecules. This reactivity is high and indiscriminate, so this free radical rarely diffuses away from sites of generation. Their lethal effects on bacterial cells are probably due to the following mechanisms: damage to the bacterial cytoplasmic membrane, protein denaturation, and damage to the DNA. The mechanisms above of HAP in contribution to the Fe3 O4 NPs antibacterial mechanism showed outstanding results in this work. On the other hand, zirconium has good cytocompatibility and antibacterial properties, and zirconium oxide having the ability to inhibit bacterial colonisation on the surface. The probable mechanism action of ZrO2 comes from their interaction with thiol group compounds found in the respiratory enzymes of bacterial cells. Zirconium binds to the bacterial cell wall and cell membrane and inhibits the respiration process.

Due to their extremely large surface area, which provides better contact with microorganisms, it's expected that nanosized Fe3 O4 /ZrO2 show high efficient antimicrobial property. The NPs get attached to the cell membrane and also penetrate inside the bacteria. The bacterial membrane contains sulphur‐containing proteins and the NPs interact with these proteins in the cell as well as with the phosphorus‐containing compounds like DNA.

4 Conclusion

Herein, HAP and ZrO2 modificated MNPs (Fe3 O4) were synthesised and characterised by using physical and chemical techniques such as XPS, XRD, SEM, EDXA, BET, FTIR, and VSM. The antibacterial activity of NPs against S. aureus and E. coli was investigated. Obtained results proved that although both MNPs have good antibacterial properties, however, Fe3 O4 /HAP NP has greater antibacterial performance than Fe3 O4 /ZrO2 and Fe3 O4. Also, S. aureus bacteria are more sensitive to both NPs based on MIC and MBC studies. These nanocomposites combine the advantages of MNP and antibacterial effects, with distinctive merits including easy preparation, high inactivation capacity, and easy isolation from sample solutions by the application of an external magnetic field.

5 Acknowledgments

The authors gratefully acknowledge the NSTRI and Payame Noor University for providing facilities for this work.

6 References

  • 1. Kapil A.: ‘The challenge of antibiotic resistance: need to contemplate’, Indian J. Med. Res., 2005, 121, (2), p. 83 [PubMed] [Google Scholar]
  • 2. Neu H.C.: ‘The crisis in antibiotic resistance’, Science, 1992, 257, (5073), pp. 1064 –1074 [DOI] [PubMed] [Google Scholar]
  • 3. Faraji M. Yamini Y. Rezaee M.: ‘Magnetic nanoparticles: synthesis, stabilization, functionalization, characterization, and applications’, J. Iran. Chem. Soc., 2010, 7, (1), pp. 1 –37 [Google Scholar]
  • 4. Lu A.H. Salabas E.E.L. Schüth F.: ‘Magnetic nanoparticles: synthesis, protection, functionalization, and application’, Angew. Chem., Int. Ed., 2007, 46, (8), pp. 1222 –1244 [DOI] [PubMed] [Google Scholar]
  • 5. Behera S.S. Patra J.K. Pramanik K. et al.: ‘Characterization and evaluation of antibacterial activities of chemically synthesized iron oxide nanoparticles’, World J. Nano Sci. Eng., 2012, 2, (4), p. 196 [Google Scholar]
  • 6. Chen W.J. Tsai P.J. Chen Y.C.: ‘Functional Fe3 O4 /TiO2 core/shell magnetic nanoparticles as photokilling agents for pathogenic bacteria’, Small, 2008, 4, (4), pp. 485 –491 [DOI] [PubMed] [Google Scholar]
  • 7. Chudasama B. Vala A.K. Andhariya N. et al.: ‘Enhanced antibacterial activity of bifunctional Fe3 O4 ‐Ag core‐shell nanostructures’, Nano Res., 2009, 2, (12), pp. 955 –965 [Google Scholar]
  • 8. Dong A. Lan S. Huang J. et al.: ‘Modifying Fe3 O4 ‐functionalized nanoparticles with N‐halamine and their magnetic/antibacterial properties’, ACS Appl. Mater. Interfaces, 2011, 3, (11), pp. 4228 –4235 [DOI] [PubMed] [Google Scholar]
  • 9. Gong P. Li H. He X. et al.: ‘Preparation and antibacterial activity of Fe3 O4 @Ag nanoparticles’, Nanotechnology, 2007, 18, (28), p. 285604 [Google Scholar]
  • 10. Gu H. Ho P.‐L. Tsang K.W. et al.: ‘Using biofunctional magnetic nanoparticles to capture vancomycin‐resistant enterococci and other gram‐positive bacteria at ultralow concentration’, J. Am. Chem. Soc., 2003, 125, (51), pp. 15702 –15703 [DOI] [PubMed] [Google Scholar]
  • 11. Gustafsson S. Fornara A. Petersson K. et al.: ‘Evolution of structural and magnetic properties of magnetite nanoparticles for biomedical applications’, Cryst. Growth Des., 2010, 10, (5), pp. 2278 –2284 [Google Scholar]
  • 12. Huang W.C. Tsai P.J. Chen Y.C.: ‘Multifunctional Fe3 O4 @Au nanoeggs as photothermal agents for selective killing of nosocomial and antibiotic‐resistant bacteria’, Small, 2009, 5, (1), pp. 51 –56 [DOI] [PubMed] [Google Scholar]
  • 13. Kong H. Song J. Jang J.: ‘One‐step fabrication of magnetic Γ‐Fe2 O3 /polyrhodanine nanoparticles using in situ chemical oxidation polymerization and their antibacterial properties’, Chem. Commun., 2010, 46, (36), pp. 6735 –6737 [DOI] [PubMed] [Google Scholar]
  • 14. Mahmoudi M. Serpooshan V.: ‘Silver‐coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat’, ACS nano, 2012, 6, (3), pp. 2656 –2664 [DOI] [PubMed] [Google Scholar]
  • 15. Mosaiab T. Jeong C.J. Shin G.J. et al.: ‘Recyclable and stable silver deposited magnetic nanoparticles with poly (vinyl pyrrolidone)‐catechol coated iron oxide for antimicrobial activity’, Mater. Sci. Eng. C, 2013, 33, (7), pp. 3786 –3794 [DOI] [PubMed] [Google Scholar]
  • 16. Sureshkumar M. Siswanto D.Y. Lee C.‐K.: ‘Magnetic antimicrobial nanocomposite based on bacterial cellulose and silver nanoparticles’, J. Mater. Chem., 2010, 20, (33), pp. 6948 –6955 [Google Scholar]
  • 17. Tran N. Webster T.J.: ‘Magnetic nanoparticles: biomedical applications and challenges’, J. Mater. Chem., 2010, 20, (40), pp. 8760 –8767 [Google Scholar]
  • 18. Wang L. Luo J. Shan S. et al.: ‘Bacterial inactivation using silver‐coated magnetic nanoparticles as functional antimicrobial agents’, Anal. Chem., 2011, 83, (22), pp. 8688 –8695 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Yu T.‐J. Li P.‐H. Tseng T.‐W. et al.: ‘Multifunctional Fe3 O4 /alumina core/shell mnps as photothermal agents for targeted hyperthermia of nosocomial and antibiotic‐resistant bacteria’, Nanomedicine, 2011, 6, (8), pp. 1353 –1363 [DOI] [PubMed] [Google Scholar]
  • 20. Kipp J.: ‘The role of solid nanoparticle technology in the parenteral delivery of poorly water‐soluble drugs’, Int. J. Pharm., 2004, 284, (1), pp. 109 –122 [DOI] [PubMed] [Google Scholar]
  • 21. Tourinho F.A. Depeyrot J. Silva G.J.D. et al.: ‘Electric double layered magnetic fluids based on spinel ferrite nanostructures’, 1998.
  • 22. Feris K. Otto C. Tinker J. et al.: ‘Electrostatic interactions affect nanoparticle‐mediated toxicity to gram‐negative bacterium pseudomonas aeruginosa Pao1’, Langmuir, 2009, 26, (6), pp. 4429 –4436 [DOI] [PubMed] [Google Scholar]
  • 23. Gajjar P. Pettee B. Britt D.W. et al.: ‘Antimicrobial activities of commercial nanoparticles against an environmental soil microbe, pseudomonas Putida Kt2440’, J. Biol. Eng., 2009, 3, (1), p. 9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Jiang W. Mashayekhi H. Xing B.: ‘Bacterial toxicity comparison between nano‐ and micro‐scaled oxide particles’, Environ. Pollut., 2009, 157, (5), pp. 1619 –1625 [DOI] [PubMed] [Google Scholar]
  • 25. Ruparelia J.P. Chatterjee A.K. Duttagupta S.P. et al.: ‘Strain specificity in antimicrobial activity of silver and copper nanoparticles’, Acta Biomat., 2008, 4, (3), pp. 707 –716 [DOI] [PubMed] [Google Scholar]
  • 26. Simon‐Deckers A. Loo S. Mayne‐L'hermite M. et al.: ‘Size‐, composition‐and shape‐dependent toxicological impact of metal oxide nanoparticles and carbon nanotubes toward bacteria’, Environ. Sci. Technol., 2009, 43, (21), pp. 8423 –8429 [DOI] [PubMed] [Google Scholar]
  • 27. Sinha R. Karan R. Sinha A. et al.: ‘Interaction and nanotoxic effect of Zno and Ag nanoparticles on mesophilic and halophilic bacterial cells’, Bioresour. Technol., 2011, 102, (2), pp. 1516 –1520 [DOI] [PubMed] [Google Scholar]
  • 28. Tsuang Y.H. Sun J.S. Huang Y.C. et al.: ‘Studies of photokilling of bacteria using titanium dioxide nanoparticles’, Artif. Organs, 2008, 32, (2), pp. 167 –174 [DOI] [PubMed] [Google Scholar]
  • 29. Wang Z. Lee Y.‐H. Wu B. et al.: ‘Anti‐microbial activities of aerosolized transition metal oxide nanoparticles’, Chemosphere, 2010, 80, (5), pp. 525 –529 [DOI] [PubMed] [Google Scholar]
  • 30. Saravanan M. Nanda A.: ‘Extracellular synthesis of silver bionanoparticles from aspergillus clavatus and its antimicrobial activity against Mrsa and Mrse’, Colloids Surf. B, Biointerfaces, 2010, 77, (2), pp. 214 –218 [DOI] [PubMed] [Google Scholar]
  • 31. Chen W.‐Y. Lin J.‐Y. Chen W.‐J. et al.: ‘Functional gold nanoclusters as antimicrobial agents for antibiotic‐resistant bacteria’, Nanomedicine, 2010, 5, (5), pp. 755 –764 [DOI] [PubMed] [Google Scholar]
  • 32. Zhao X. Shi Y. Cai Y. et al.: ‘Cetyltrimethylammonium bromide‐coated magnetic nanoparticles for the preconcentration of phenolic compounds from environmental water samples’, Environ. Sci. Technol., 2008, 42, (4), pp. 1201 –1206 [DOI] [PubMed] [Google Scholar]
  • 33. Saravanan S. Nethala S. Pattnaik S. et al.: ‘Preparation, characterization and antimicrobial activity of a bio‐composite scaffold containing chitosan/nano‐hydroxyapatite/nano‐silver for bone tissue engineering’, Int. J. Biol. Macromol., 2011, 49, (2), pp. 188 –193 [DOI] [PubMed] [Google Scholar]
  • 34. Stanić V. Dimitrijević S. Antić‐Stanković J. et al.: ‘Synthesis, characterization and antimicrobial activity of copper and zinc‐doped hydroxyapatite nanopowders’, Appl. Surf. Sci., 2010, 256, (20), pp. 6083 –6089 [Google Scholar]
  • 35. Gouda M.: ‘Nano‐zirconium oxide and nano‐silver oxide/cotton gauze fabrics for antimicrobial and wound healing acceleration’, J. Ind. Text, 2012, 41, (3), pp. 222 –240 [Google Scholar]
  • 36. Huang H.‐L. Chang Y.‐Y. Chen Y.‐C. et al.: ‘Cytocompatibility and antibacterial properties of zirconia coatings with different silver contents on titanium’, Thin Solid Films, 2013, 549, pp. 108 –116 [Google Scholar]
  • 37. Jangra S.L. Stalin K. Dilbaghi N. et al.: ‘Antimicrobial activity of zirconia (ZrO2) nanoparticles and zirconium complexes’, J. Nanosci. Nanotechnol., 2012, 12, (9), pp. 7105 –7112 [DOI] [PubMed] [Google Scholar]
  • 38. Bagherzadeh M. Amrollahi M. Makizadeh S.: ‘Decoration of Fe3 O4 magnetic nanoparticles on graphene oxide nanosheets’, RSC Adv., 2015, 5, (128), pp. 105499 –105506 [Google Scholar]
  • 39. Bagherzadeh M. Haddadi H. Iranpour M.: ‘Electrochemical evaluation and surface study of magnetite/pani nanocomposite for carbon steel protection in 3.5% NaCl’, Prog. Org. Coat., 2016, 101, pp. 149 –160 [Google Scholar]
  • 40. Riahi F. Bagherzadeh M. Hadizadeh Z.: ‘Modification of Fe3 O4 superparamagnetic nanoparticles with zirconium oxide; preparation, characterization and its application toward fluoride removal’, RSC Adv., 2015, 5, (88), pp. 72058 –72068 [Google Scholar]
  • 41. Salem W. Leitner D.R. Zingl F.G. et al.: ‘Antibacterial activity of silver and zinc nanoparticles against Vibrio cholerae and enterotoxic Escherichia coli ’, Int. J. Med. Microbiol., 2015, 305, (1), pp. 85 –95 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Xu X. Deng C. Gao M. et al.: ‘Synthesis of magnetic microspheres with immobilized metal ions for enrichment and direct determination of phosphopeptides by matrix‐assisted laser desorption ionization mass spectrometry’, Adv. Mater., 2006, 18, (24), pp. 3289 –3293 [Google Scholar]
  • 43. Zhou S. Garnweitner G. Niederberger M. et al.: ‘Dispersion behavior of zirconia nanocrystals and their surface functionalization with vinyl group‐containing ligands’, Langmuir, 2007, 23, (18), pp. 9178 –9187 [DOI] [PubMed] [Google Scholar]
  • 44. Chang K. Ji W. Li C. et al.: ‘The effect of varying carboxylic‐group content in reduced graphene oxides on the anticorrosive properties of pmma/reduced graphene oxide composites’, Express. Polym. Lett., 2014, 8, (12), pp. 908 –919 [Google Scholar]
  • 45. Feng Q.L. Wu J. Chen G. et al.: ‘A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus ’, J. Biomed. Mater. Res., 2000, 52, (4), pp. 662 –668 [DOI] [PubMed] [Google Scholar]
  • 46. Sondi I. Salopek‐Sondi B.: ‘Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for gram‐negative bacteria’, J. Colloid Interface Sci., 2004, 275, (1), pp. 177 –182 [DOI] [PubMed] [Google Scholar]
  • 47. Nel A.E. Mädler L. Velegol D. et al.: ‘Understanding biophysicochemical interactions at the nano–bio interface’, Nature Mater., 2009, 8, (7), p. 543 [DOI] [PubMed] [Google Scholar]
  • 48. Soenen S.J. Rivera‐Gil P. Montenegro J.‐M. et al.: ‘Cellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluation’, Nano Today, 2011, 6, (5), pp. 446 –465 [Google Scholar]
  • 49. Lin D. Xing B.: ‘Phytotoxicity of nanoparticles: inhibition of seed germination and root growth’, Environ. Pollut., 2007, 150, (2), pp. 243 –250 [DOI] [PubMed] [Google Scholar]
  • 50. Baker C. Pradhan A. Pakstis L. et al.: ‘Synthesis and antibacterial properties of silver nanoparticles’, J. Nanosci. Nanotechnol., 2005, 5, (2), pp. 244 –249 [DOI] [PubMed] [Google Scholar]
  • 51. Lee H. Yeo S.Y. Jeong S.H.: ‘Antibacterial effect of nanosized silver colloidal solution on textile fabrics’, J. Mater. Sci., 2003, 38, (10), pp. 2199 –2204 [Google Scholar]
  • 52. Morones J.R. Elechiguerra J.L. Camacho A. et al.: ‘The bactericidal effect of silver nanoparticles’, Nanotechnology, 2005, 16, (10), p. 2346 [DOI] [PubMed] [Google Scholar]
  • 53. Karlsson H.L. Gustafsson J. Cronholm P. et al.: ‘Size‐dependent toxicity of metal oxide particles – a comparison between nano‐ and micrometer size’, Toxicol. Lett., 2009, 188, (2), pp. 112 –118 [DOI] [PubMed] [Google Scholar]
  • 54. Müller K. Skepper J.N. Posfai M. et al.: ‘Effect of ultrasmall superparamagnetic iron oxide nanoparticles (ferumoxtran‐10) on human monocyte‐macrophages in vitro’, Biomaterials, 2007, 28, (9), pp. 1629 –1642 [DOI] [PubMed] [Google Scholar]
  • 55. Singh N. Jenkins G.J. Asadi R. et al.: ‘Potential toxicity of superparamagnetic iron oxide nanoparticles (spion)’, Nano Rev., 2010, 1, (1), p. 5358 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Berry C.C. Curtis A.S.: ‘Functionalisation of magnetic nanoparticles for applications in biomedicine’, J. Phys. D, Appl. Phys., 2003, 36, (13), p. R198 [Google Scholar]
  • 57. Berry C.C. Wells S. Charles S. et al.: ‘Cell response to dextran‐derivatised iron oxide nanoparticles post internalisation’, Biomaterials, 2004, 25, (23), pp. 5405 –5413 [DOI] [PubMed] [Google Scholar]
  • 58. Berry C.C. Wells S. Charles S. et al.: ‘Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro’, Biomaterials, 2003, 24, (25), pp. 4551 –4557 [DOI] [PubMed] [Google Scholar]
  • 59. Chifiriuc C. Lazar V. Bleotu C. et al.: ‘Bacterial adherence to the cellular and inert substrate in the presence of CoFe2 O4 and Fe3 O4 /oleic acid‐core/shell’, Dig. J. Nanomater. Biostruct., 2011, 6, (1), pp. 37 –42 [Google Scholar]
  • 60. Ebrahiminezhad A. Davaran S. Rasoul‐Amini S. et al.: ‘Synthesis, characterization and anti‐listeria monocytogenes effect of amino acid coated magnetite nanoparticles’, Curr. Nanosci., 2012, 8, (6), pp. 868 –874 [Google Scholar]
  • 61. Ebrahiminezhad A. Ghasemi Y. Rasoul‐Amini S. et al.: ‘Impact of amino‐acid coating on the synthesis and characteristics of iron‐oxide nanoparticles (ions)’, Bull. Korean Chem. Soc., 2012, 33, (12), pp. 3957 –3962 [Google Scholar]

Articles from IET Nanobiotechnology are provided here courtesy of Wiley

RESOURCES